Skip to main content

Evidence-Based Supplement Research

Evidence-Based Supplement Research

Peony and Reduced Disease Activity Index

Safety in these studies

adverse reactions (overall incidence)No significant differenceOR=0.93, 95% CI: 0.45 to 1.91, Z=0.20, P=.84
there was no significant difference in the incidence of adverse reactions (OR=0.93, 95%CI: 0.45 to 1.91, Z=0.20, P=.84)
from: The effectiveness and safety of total glucosides of paeony in systemic lupus erythematosus

1 of 1 paper

The effectiveness and safety of total glucosides of paeony in systemic lupus erythematosus: A systematic review and meta-analysis.
- 2022-12-16
- Meta-Analysis · n = 836
- Medicine 101(50)
- - Mengjie Wang
  - Zhiyuan Wang
  - Ying Liu
  - Lei Wang
  - Xiaomeng Wang
  - Ping Jiang
- PubMed: 36550839
- DOI: 10.1097/md.0000000000032029
10 Insights on
- Reduced Disease Activity Index
- High evidence
- Clinical
reduced SLE Disease Activity Index (SLEDAI) (MD = -1.70, 95%CI: -2.51 to -0.89, Z = 4.11, P < .0001)
Effect
Beneficial
Effect size
Moderate
Significant
Yes